Breast cancer survival in India across 11 geographic areas under the National Cancer Registry Programme
Krishnan Sathishkumar,Jayasankar Sankarapillai,Aleyamma Mathew,Rekha A. Nair,Nitin Gangane,Sushma Khuraijam,Debabrata Barmon,Shashank Pandya,Gautam Majumdar,Vinay Deshmane,Eric Zomawia,Tseten Wangyal Bhutia,Kaling Jerang,Preethi Sara George,Swapna Maliye,Rajesh Laishram,Gaurav Das,Anand Shah,Shiromani Debbarma,Shravani Koyande,Lalawmpuii Pachuau,Ashok Sherpa,Gegong Jongkey,Meesha Chaturvedi,Priyanka Das,Stephen Santhappan,Prashant Mathur
DOI: https://doi.org/10.1002/cncr.35188
IF: 6.9209
2024-01-08
Cancer
Abstract:Background Population‐based cancer survival is a key indicator for assessing the effectiveness of cancer control by a health care system in a specific geographic area. Breast cancer is the most common cancer among women in India, accounting for over one quarter of all female cancers. The objective of this study was to estimate the 5‐year survival of female patients who were diagnosed with breast cancer between 2012 and 2015 from the existing Population‐Based Cancer Registries (PBCRs) in India. Methods In total, 17,331 patients who had breast cancer diagnosed between 2012 and 2015 from 11 PBCRs were followed until June 30, 2021. Active methods were used to track the vital status of registered breast cancer cases. The study conducted survival analysis by calculating the difference between the date of first diagnosis and the date of death or censoring to estimate observed survival and relative survival using the actuarial survival approach and the Ederer‐II approach, respectively. Results The 5‐year age‐standardized relative survival (95% confidence interval [CI]) of patients with breast cancer was 66.4% (95% CI, 65.5%–67.3%). Mizoram (74.9%; 95% CI, 68.1%–80.8%), Ahmedabad urban (72.7%; 95% CI, 70.3%–74.9%), Kollam (71.5%; 95% CI, 69.2%–73.6%), and Thiruvananthapuram (69.1%; 95% CI, 67.0%–71.2%) had higher survival rates than the national average. Conversely, Pasighat had the lowest survival rate (41.9%; 95% CI, 14.7%–68.6%). The 5‐year observed survival rates for localized, regional, and distant metastasis in the pooled PBCRs were 81.0%, 65.5%, and 18.3%, respectively. Conclusions The overall disparity in survival rates was observed across 11 PBCRs, with lower survival rates reported in Manipur, Tripura, and Pasighat. Therefore, it is imperative to implement comprehensive cancer control strategies widely throughout the country.
oncology